While men across the country will be sprouting moustaches to raise money this Movember, the Queen Elizabeth Hospital is also playing its’ part in the battle against Prostate Cancer.
Prostate is the second most common form of cancer in men with 47,000 cases diagnosed annually.
The hospital is currently supporting 122 national studies into a range of conditions and has increased its number of trials open by 15% in the last year.
Head of Research and Development Antonia Hardcastle said: “I think many people in the community would be surprised at how active we are in various research fields including prostate.”
“We are very fortunate that people in this area are very altruistic and are willing to give something back to help future generations. All of the studies completed at the hospital are in advanced stages and have already completed substantial testing.”
The research projects into prostate cancer supported at the QEH range from genetic testing to drug trials in a bid to tackle this disease. Currently 54 patients are taking part in the ProMPTS study, which looks at how cancer grows and 166 have joined our two genetics studies. We are looking for a further 8 patients to take part in our enzalutimide trial named Premise, and are actively recruiting to the Add-Aspirin trial. Details of all these trials together with the eligibility criteria can be found at http://www.ukctg.nihr.ac.uk
Anyone interested in taking part in a trial is welcome to contact the Research & Development department on 01553 613532 or email Research&Development@qehkl.nhs.uk
—ENDS—
Members of the Research and Development Team with their Movember Moustaches
QEH Media Hub 